Index of reports
> Cases with Hyponatraemia (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Atrovent (Ipratropium) where reactions include hyponatraemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Atrovent side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-23
Patient: 61 year old female
Reactions: Hyponatraemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Atrovent
Dosage: unk
Altace
Dosage: 1.25 mg, unk
Atorvastatin Calcium
Dosage: unk
Exemestane
Dosage: 25 mg, unk
Indication: Breast Cancer
Start date: 2010-01-01
Bendrofluazide
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hypertension
Anastrozole
Dosage: 1 mg, unk
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-01-01
End date: 2010-01-01
Lercanidipine
Dosage: unk
Other drugs received by patient: Amoxicillin; Prednisolone
Possible Atrovent side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-21
Patient: 61 year old female
Reactions: Hyponatraemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Altace
Dosage: 1.25 mg, unk
Atrovent
Dosage: unk
Atorvastatin Calcium
Dosage: unk
Bendrofluazide
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hypertension
Lercanidipine
Dosage: unk
Exemestane
Dosage: 25 mg, unk
Indication: Breast Cancer
Start date: 2010-01-01
Anastrozole
Dosage: 1 mg, unk
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-01-01
Other drugs received by patient: Amoxicillin; Prednisolone
Possible Atrovent side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-21
Patient: 61 year old female
Reactions: Hyponatraemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Exemestane
Dosage: 25 mg, unk
Indication: Breast Cancer
Start date: 2010-01-01
Altace
Dosage: 1.25 mg, unk
Anastrozole
Dosage: 1 mg, unk
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-01-01
End date: 2010-01-01
Bendrofluazide
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hypertension
Lercanidipine
Dosage: unk
Atorvastatin Calcium
Dosage: unk
Atrovent
Dosage: unk
Other drugs received by patient: Amoxicillin; Prednisolone
Possible Atrovent side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-14
Patient: 61 year old female
Reactions: Hyponatraemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Exemestane
Dosage: 25 mg, unk
Indication: Breast Cancer
Start date: 2010-01-01
Atorvastatin Calcium
Dosage: unk
Anastrozole
Dosage: 1 mg, unk
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-01-01
Altace
Dosage: 1.25 mg, unk
Bendrofluazide
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hypertension
Atrovent
Dosage: unk
Lercanidipine
Dosage: unk
Other drugs received by patient: Amoxicillin; Prednisolone
|